Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
46 Cards in this Set
- Front
- Back
_______ disease is the second most common degenerative nerve disease
|
Parkinson's
|
|
The most commonly prescribed drug for Parkinson's is
|
Levodopa
|
|
The most effective therapy for Parkinson's is a combination of Levodopa and ________
|
Carbidopa
|
|
Parkinson's damages the ________ system: a complex neuronal network that regulates movement.
|
Extrapyramidal
|
|
The complete absence of movement is called ______
|
Akinesia
|
|
PD causes degeneration of neurons in the substantia nigra, resulting in an imbalance of ______ and ______
|
Dopamine, Acetylcholine
|
|
Inadequate Dopamine causes ACh to be unopposed, causing excessive stimulation of neurons that release ______
|
gamma-aminobutyric acid (GABA)
|
|
Overactivity of ______ causes the motor symptoms that characterize PD.
|
GABA
|
|
Non-motor symptoms of PD include
|
autonomic dysfunction, depression, psychosis, and dementia
|
|
The goal of the drugs used to treat PD is to restore balance between _____ and _____
|
Dopamine, ACh
|
|
Motor symptoms are treated by drugs that activate _____ receptors, or block ______ receptors.
|
Dopamine, Cholinergic
|
|
Drugs that activate Dopamine receptors are called
|
Dopaminergic Agents
|
|
Drugs that block ACh receptors are called
|
Anticholinergic Agents
|
|
Which group of drugs (Dopaminergic Agents or Anticholinergic Agents) are more widely employed to treat PD?
|
Dopaminergic Agents
|
|
Which popular PD drug promotes dopamine synthesis?
|
Levodopa
|
|
Which drugs prevent dopamine breakdown?
|
Inhibitors of monoamine-oxidase B (MAO-B)
|
|
These drugs activate dopamine receptors directly
|
Dopamine agonists (DA)
|
|
An oral non-ergot dopamine agonist, ______ is a first-line drug for motor symptoms of PD.
|
Pramipexole
|
|
Adverse effects of Pramipexole include
|
nausea, dyskinesia, postural hypotension, and hallucinations—result from excessive activation of dopamine receptors.
|
|
_______ is a COMT inhibitor that is combined with levodopa to enhance levodopa effects. The drug inhibits metabolism of levodopa by COMT in the intestine and peripheral tissues, thereby making more levodopa available to the brain.
|
Entacapone
|
|
_______ and ______enhance responses to levodopa by inhibiting MAO-B, the brain enzyme that inactivates dopamine
|
Selegiline and rasagiline
|
|
__________relieve symptoms of PD by blocking cholinergic receptors in the striatum.
|
Anticholinergics
|
|
__________promotes dopamine release (and may also block dopamine reuptake).
|
Amantadine
|
|
The inhibitors of ________ enhance the effects of levodopa by blocking its degradation.
|
catecholamine-O-methyltransferase (COMT)
|
|
All of the ______ ______share the same mechanism: blockade of muscarinic receptors in the striatum.
|
Anticholinergic Agents
|
|
Initial treatment of patients with mild symptoms should begin with ______ or ______
|
Selegiline, Rasagiline
|
|
For patients with more severe symptoms, treatment should begin with either ______ or a ______ ______
|
Levodopa, Dopamine Antagonist
|
|
Long term treatment with Levodopa can cause ______ ______ ______, which are basically involuntary movements.
|
Drug-induced dyskinesias
|
|
A loss of symptom relief after long term Levodopa treatment is known as an ______ ______
|
"off" time
|
|
A brief interruption in treatment (eg, 10 days) is called a ______ ______
|
Drug Holiday
|
|
In PD patients, neurotransmission is disrupted primarily in the ______, an important component of the extrapyramidal system.
|
Striatum
|
|
Neurons that supply dopamine to the striatum originate in the ______ ______
|
Substantia nigra
|
|
Near the end of the Levodopa dosing interval _____ _____ indicates that drug levels have declined to subtherapeutic levels
|
"wearing off" (or gradual loss)
|
|
Abrupt loss of effect (on-off phenomenon) may be triggered by a meal high in _______
|
Protein
|
|
_________ enhances the effects of levodopa by preventing decarboxylation of levodopa in the intestine and peripheral tissues
|
Carbidopa
|
|
An alkaloid found in plants and used in some dopamine agonist drugs is called ______
|
Ergot
|
|
Dopamine Agonists are divided into two groups. What are they?
|
Ergot derivatives and Non-Ergot derivatives
|
|
T or F: Ergot derivatives are preferred over non-ergot derivatives in treating Parkinson's.
|
False: Non-ergot derivatives are highly selective for dopamine receptors and thus have fewer side effects than ergot derivatives that activate other receptors
|
|
What two ergot derivatives activate serotonergic and alpha-adrenergic receptors causing nightmares, agitation, and delusions?
|
bromocriptine and cabergoline
|
|
pramipexole, ropinirole, and apomorphine are examples of
|
non-ergot derivatives
|
|
"Sleep attacks" are a major adverse effect of what drug?
|
Pramipexole
|
|
Drugs that inhibit the metabolism of Levodopa are known as ____ _____
|
COMP Inhibitors
|
|
T or F: Of the two COMP Inhibitors, Entacapone is preferred over Tolcapone.
|
True: Entacapone is safer and more effective than Tolcapone.
|
|
Selegiline and rasagiline enhance responses to levodopa by inhibiting ________, the brain enzyme that inactivates dopamine.
|
MAO-B
|
|
_________drugs alleviate symptoms by blocking muscarinic receptors in the striatum, thereby improving the functional imbalance between dopamine and ACh.
|
Anticholinergic
|
|
T or F: Anticholinergic are used as second-line therapy for tremors and have been used since 1867 making them the oldest medicines to treat Parkinson's
|
True
|